Global DNA Microarray Market - Analysis, Technologies & Forecasts to 2020 - Rising Focus on Drug Discovery & Development - Research and Markets

DUBLIN, October 17, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Global DNA Microarray Market 2016-2020" report to their offering.

The report forecasts the global DNA microarray market to grow at a CAGR of 15.16% during the period 2016-2020.

Growing popularity of personalized medicines will be a key trend for market growth. The popularity of DNA microarray technology is growing as it helps in the early detection of diseases, and selection of accurate treatment methods can reduce mortality rates. DNA microarray technology enables researchers to analyze critical biological complications such as the genomic variations and nature of inherited syndromes that cause cardiovascular diseases and cancers.

According to the report, advances in technology will be a key driver for market growth. Rapid advances in technology related to DNA microarray has equipped related solutions to produce results with high efficiency, accuracy, specificity, and reproducibility in target identification, primary screening, and toxicity study in drug discovery and research. The technological advances in DNA microarray have also enabled solutions to be applied in clinics, commercial laboratories and research institutions, and hospitals to detect DNA and proteins with the motive of disease diagnosis, drug discovery, and disease monitoring that has significantly increased the acceptance and adoption of these solutions.

Further, the report states that the laws and regulations of the approval process for diagnostic devices vary across all countries, which is a major challenge faced by MNCs. In addition, any change in regulatory policies by different governing bodies including National Institutes of Health (NIH), National Human Genome Research Institute (NHGRI), and FDA during the product development period could delay the entry of potential products into the market. Many developed countries such as the US, the UK, Germany, France, Japan, Singapore, and South Korea have strict regulations regarding the approval and marketing of diagnostics products.

Key vendors:

• Agilent Technologies
• Illumina
• Merck
• Thermo Fisher Scientific

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Market landscape

PART 06: Market segmentation by application

PART 07: Market segmentation by product type

PART 08: Geographical segmentation

PART 09: Market drivers

PART 10: Impact of drivers

PART 11: Market challenges

PART 12: Impact of drivers and challenges

PART 13: Market trends

PART 14: Vendor landscape

PART 15: Key vendor analysis

PART 16: Appendix

For more information on this topic, check out the Pharmaceuticals and Healthcare section of the Research and Markets' blog.

For more information about this report visit http://www.researchandmarkets.com/research/6b8tqc/global_dna

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716